Entry Detail



General Information

Database ID:exR0080621
RNA Name:RPLP1
RNA Type:mRNA
Chromosome:chr15
Starnd:+
Coordinate:
Start Site(bp):69452814End Site(bp):69456205
External Links:ENSG00000137818



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC245033.1
chr15
82536788
82573194
-
ACOT9
chrX
23701055
23766475
-
AC004922.1
chr7
99325879
99394653
+
AFAP1L2
chr10
114294824
114404756
-
AGO3
chr1
35930718
36072500
+
ACTC1
chr15
34790230
34795549
-
AIG1
chr6
143060496
143341058
+
AGPAT1
chr6
32168212
32178096
-
ACTB
chr7
5527148
5563784
-
AHSA1
chr14
77457870
77469472
+
ADGRA3
chr4
22345071
22516066
-
ADRM1
chr20
62302093
62308862
+
AIFM1
chrX
130129362
130165887
-
ACADS
chr12
120725774
120740008
+
ABHD5
chr3
43690108
43734371
+
ADA
chr20
44619522
44652233
-
ACAA2
chr18
49782164
49813953
-
AC092143.1
chr16
89919165
89936092
+
AGPAT5
chr8
6708642
6761503
+
AL133352.1
chr10
100505628
100529881
-
AFF4
chr5
132875395
132963634
-
ADH5
chr4
99070978
99088801
-
AC023055.1
chr12
55757275
55827546
-
AC007192.1
chr19
18153158
18178117
+
AEBP2
chr12
19404045
19720801
+
AC118549.1
chr1
77562416
77683419
-
AC090517.4
chr15
56652488
56918571
-
AC010132.3
chr7
42909273
42932174
-
AGPAT3
chr21
43865223
43987592
+
AC010422.3
chr19
12643831
12648397
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-302b-3p
chr4
112648489
112648511
-
hsa-miR-3917
chr1
25906384
25906403
-
hsa-miR-4426
chr1
192716333
192716349
+
hsa-miR-4707-5p
chr14
22956998
22957020
-
hsa-miR-4707-3p
chr14
22956957
22956978
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC004951.4
chr7
43951910
44019151
-
AC005618.1
chr5
141326210
141329357
+
AC007613.1
chr16
11741910
11744506
+
AC009403.1
chr7
155611231
155645205
-
AC009403.2
chr7
155474256
155644406
-
AC020928.2
chr19
36773712
36775908
-
AC022400.3
chr10
73674295
73730466
-
AC022400.5
chr10
73699151
73730487
-
AC060780.1
chr17
43148368
43171037
-
AC104793.1
chr4
161378953
161388417
+
AC245014.3
chr1
145281116
145281462
+
AL049795.2
chr1
32170733
32176568
+
AL117378.1
chr6
131901963
131920565
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA